| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000020538 |
| Receipt No. | R000023697 |
| Official scientific title of the study | Enhanced recovery program emphasizing preoperative carbohydrate loading is safe and improves postoperative insulin resistance in gastrectomy patients: a randomized controlled trial |
| Date of disclosure of the study information | 2016/01/13 |
| Last modified on | 2018/06/02 (Ver. 6) |
| Basic information | ||
| Official scientific title of the study | Enhanced recovery program emphasizing preoperative carbohydrate loading is safe and improves postoperative insulin resistance in gastrectomy patients: a randomized controlled trial | |
| Title of the study (Brief title) | Enhanced recovery program emphasizing preoperative carbohydrate loading is safe and improves postoperative insulin resistance in gastrectomy patients: a randomized controlled trial | |
| Region |
|
|
| Condition | ||
| Condition | gastric cancer | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | We evaluated the clinical consequence of this protocol in gastric surgery, assessing not only safety but postoperative nutrition state, insulin-resistance, and quality of life (QOL). |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | We tested the noninferiority of ERAS with respect to the rate of achievement of discharge from the hospital within 12 days. |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | Active |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | In the ERAS group, intravenous fluid was restricted to a minimal daily requirement during the first 3 postoperative days. Additional intravenous fluid was administered when patient showed poor oral intake of water or food.
|
|
| Interventions/Control_2 | The conventional group received intravenous fluid for 1 week postoperatively. | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1)Patients with radical surgery is scheduled.
2)ASA(American Society of Anesthesiology)class 1-3. 3)Written informed consent must be obtained from patients. |
|||
| Key exclusion criteria | 1)obstructin
2)Patients enrollment to the study is determined to be inappropriate. |
|||
| Target sample size | 80 | |||
| Research contact person | |
| Name of lead principal investigator | Ohdan Hideki |
| Organization | Hiroshima University Hospital |
| Division name | department of gastro intestinal surgery |
| Address | 1-2-3 kasumi, minami-ku, Hiroshima city, Japan |
| TEL | 082-257-5222 |
| ktanabe2@hiroshima-u.ac.jp | |
| Public contact | |
| Name of contact person | Tanbe Kazuaki |
| Organization | Hiroshima University Hospital |
| Division name | department of gastro intestinal surgery |
| Address | 1-2-3 Kasumi, Minami-ku, Hiroshima |
| TEL | 082-257-5222 |
| Homepage URL | http://home.hiroshima-u.ac.jp/home2ge/ |
| ktanabe2@hiroshima-u.ac.jp | |
| Sponsor | |
| Institute | Hiroshima University Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Hiroshima University Hospital |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Partially published |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000023697 |